| CEO Name | Norman Schwartz |
| Nationality | United States |
| Net Worth Estimation | $100 million |
Norman Schwartz's estimated net worth of around $100 million derives mainly from his long tenure as CEO and Chairman of Bio-Rad Laboratories, Inc., substantial stock ownership, and compensation packages, including salary, bonuses, and equity awards. Persistent growth in Bio-Rad's market capitalization and share price has significantly increased the value of his holdings and investments.
Norman Schwartz's estimated net worth of $100,000,000 exceeds the typical healthcare CEO range of $10,000,000 to $90,000,000 by approximately 11%. His wealth places him above the maximum norm, indicating exceptional financial standing among peers in the industry.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Norman Schwartz Performance in Bio-Rad Laboratories, Inc.
Norman Schwartz, CEO of Bio-Rad Laboratories, Inc., exhibits strategic leadership focused on innovation and operational excellence in life sciences and clinical diagnostics. His decision-making emphasizes R&D investment and market expansion, driving consistent revenue growth and enhanced shareholder value. Under his tenure, Bio-Rad has strengthened global presence and technological leadership, significantly boosting the company's competitive performance and industry standing.
Latest News
Bio-Rad Laboratories, Inc.: A Hidden Investment Gem in Life Sciences by Nisha Thakrar on Trustnet
Bio-Rad, led by CEO Norman Schwartz, is highlighted as an underappreciated but resilient powerhouse in life sciences and clinical diagnostics, with dominant positions in digital PCR, blood typing, and lab quality control solutions. Its razor-and-blade model, driven by high-margin, recurring consumable sales, provides a stable and predictable revenue stream, even amid economic uncertainty.
Source: http://www.trustnet.com/news/13461869/a-hidden-investment-gem-in-life-sciences